Cozen O’Connor: The Next Best Thing to Mensing Preemption: Winning for Lack of Connection between Marketing and the Prescriber [Drug and Device Law]

The Next Best Thing to Mensing Preemption: Winning for Lack of Connection between Marketing and the Prescriber [Drug and Device Law]

John Sullivan, a member of Cozen O'Connor's Commercial Litigation Department, discusses Whitener v. Pliva, in which the claim states that the manufacturer didn't warn about risks of the drug, in this instance, off-label risks.

To read the article, click here.


Related Attorneys

John J. Sullivan

Member

jsullivan@cozen.com

(212) 453-3729


Related Practices